List of Tables
TABLE 1. ANTIVIRAL THERAPEUTICS MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
TABLE 3. GLOBAL ANTIVIRAL THERAPEUTICS MARKET SIZE, 2018-2023 (USD MILLION)
TABLE 4. GLOBAL ANTIVIRAL THERAPEUTICS MARKET SIZE, 2024-2030 (USD MILLION)
TABLE 5. GLOBAL ANTIVIRAL THERAPEUTICS MARKET SIZE, BY REGION, 2018-2023 (USD MILLION)
TABLE 6. GLOBAL ANTIVIRAL THERAPEUTICS MARKET SIZE, BY REGION, 2024-2030 (USD MILLION)
TABLE 7. GLOBAL ANTIVIRAL THERAPEUTICS MARKET SIZE, BY DRUG, 2018-2023 (USD MILLION)
TABLE 8. GLOBAL ANTIVIRAL THERAPEUTICS MARKET SIZE, BY DRUG, 2024-2030 (USD MILLION)
TABLE 9. GLOBAL ANTIVIRAL THERAPEUTICS MARKET SIZE, BY HEPATITIS ANTIVIRAL DRUG, BY REGION, 2018-2023 (USD MILLION)
TABLE 10. GLOBAL ANTIVIRAL THERAPEUTICS MARKET SIZE, BY HEPATITIS ANTIVIRAL DRUG, BY REGION, 2024-2030 (USD MILLION)
TABLE 11. GLOBAL ANTIVIRAL THERAPEUTICS MARKET SIZE, BY HERPES ANTIVIRAL DRUG, BY REGION, 2018-2023 (USD MILLION)
TABLE 12. GLOBAL ANTIVIRAL THERAPEUTICS MARKET SIZE, BY HERPES ANTIVIRAL DRUG, BY REGION, 2024-2030 (USD MILLION)
TABLE 13. GLOBAL ANTIVIRAL THERAPEUTICS MARKET SIZE, BY HIV ANTIVIRAL DRUG, BY REGION, 2018-2023 (USD MILLION)
TABLE 14. GLOBAL ANTIVIRAL THERAPEUTICS MARKET SIZE, BY HIV ANTIVIRAL DRUG, BY REGION, 2024-2030 (USD MILLION)
TABLE 15. GLOBAL ANTIVIRAL THERAPEUTICS MARKET SIZE, BY INFLUENZA ANTIVIRAL DRUG, BY REGION, 2018-2023 (USD MILLION)
TABLE 16. GLOBAL ANTIVIRAL THERAPEUTICS MARKET SIZE, BY INFLUENZA ANTIVIRAL DRUG, BY REGION, 2024-2030 (USD MILLION)
TABLE 17. GLOBAL ANTIVIRAL THERAPEUTICS MARKET SIZE, BY THERAPY, 2018-2023 (USD MILLION)
TABLE 18. GLOBAL ANTIVIRAL THERAPEUTICS MARKET SIZE, BY THERAPY, 2024-2030 (USD MILLION)
TABLE 19. GLOBAL ANTIVIRAL THERAPEUTICS MARKET SIZE, BY DNA POLYMERASE INHIBITORS, BY REGION, 2018-2023 (USD MILLION)
TABLE 20. GLOBAL ANTIVIRAL THERAPEUTICS MARKET SIZE, BY DNA POLYMERASE INHIBITORS, BY REGION, 2024-2030 (USD MILLION)
TABLE 21. GLOBAL ANTIVIRAL THERAPEUTICS MARKET SIZE, BY DNA POLYMERASE INHIBITORS, 2018-2023 (USD MILLION)
TABLE 22. GLOBAL ANTIVIRAL THERAPEUTICS MARKET SIZE, BY DNA POLYMERASE INHIBITORS, 2024-2030 (USD MILLION)
TABLE 23. GLOBAL ANTIVIRAL THERAPEUTICS MARKET SIZE, BY NON-NUCLEOSIDES, BY REGION, 2018-2023 (USD MILLION)
TABLE 24. GLOBAL ANTIVIRAL THERAPEUTICS MARKET SIZE, BY NON-NUCLEOSIDES, BY REGION, 2024-2030 (USD MILLION)
TABLE 25. GLOBAL ANTIVIRAL THERAPEUTICS MARKET SIZE, BY PURINE NUCLEOSIDE ANALOGUES, BY REGION, 2018-2023 (USD MILLION)
TABLE 26. GLOBAL ANTIVIRAL THERAPEUTICS MARKET SIZE, BY PURINE NUCLEOSIDE ANALOGUES, BY REGION, 2024-2030 (USD MILLION)
TABLE 27. GLOBAL ANTIVIRAL THERAPEUTICS MARKET SIZE, BY PYRIMIDINE NUCLEOSIDE ANALOGUES, BY REGION, 2018-2023 (USD MILLION)
TABLE 28. GLOBAL ANTIVIRAL THERAPEUTICS MARKET SIZE, BY PYRIMIDINE NUCLEOSIDE ANALOGUES, BY REGION, 2024-2030 (USD MILLION)
TABLE 29. GLOBAL ANTIVIRAL THERAPEUTICS MARKET SIZE, BY NEURAMINIDASE INHIBITORS, BY REGION, 2018-2023 (USD MILLION)
TABLE 30. GLOBAL ANTIVIRAL THERAPEUTICS MARKET SIZE, BY NEURAMINIDASE INHIBITORS, BY REGION, 2024-2030 (USD MILLION)
TABLE 31. GLOBAL ANTIVIRAL THERAPEUTICS MARKET SIZE, BY PROTEASE INHIBITORS, BY REGION, 2018-2023 (USD MILLION)
TABLE 32. GLOBAL ANTIVIRAL THERAPEUTICS MARKET SIZE, BY PROTEASE INHIBITORS, BY REGION, 2024-2030 (USD MILLION)
TABLE 33. GLOBAL ANTIVIRAL THERAPEUTICS MARKET SIZE, BY REVERSE TRANSCRIPTASE INHIBITORS, BY REGION, 2018-2023 (USD MILLION)
TABLE 34. GLOBAL ANTIVIRAL THERAPEUTICS MARKET SIZE, BY REVERSE TRANSCRIPTASE INHIBITORS, BY REGION, 2024-2030 (USD MILLION)
TABLE 35. GLOBAL ANTIVIRAL THERAPEUTICS MARKET SIZE, BY REVERSE TRANSCRIPTASE INHIBITORS, 2018-2023 (USD MILLION)
TABLE 36. GLOBAL ANTIVIRAL THERAPEUTICS MARKET SIZE, BY REVERSE TRANSCRIPTASE INHIBITORS, 2024-2030 (USD MILLION)
TABLE 37. GLOBAL ANTIVIRAL THERAPEUTICS MARKET SIZE, BY NONNUCLEOSIDE RTIS, BY REGION, 2018-2023 (USD MILLION)
TABLE 38. GLOBAL ANTIVIRAL THERAPEUTICS MARKET SIZE, BY NONNUCLEOSIDE RTIS, BY REGION, 2024-2030 (USD MILLION)
TABLE 39. GLOBAL ANTIVIRAL THERAPEUTICS MARKET SIZE, BY NUCLEOSIDE RTIS, BY REGION, 2018-2023 (USD MILLION)
TABLE 40. GLOBAL ANTIVIRAL THERAPEUTICS MARKET SIZE, BY NUCLEOSIDE RTIS, BY REGION, 2024-2030 (USD MILLION)
TABLE 41. GLOBAL ANTIVIRAL THERAPEUTICS MARKET SIZE, BY NUCLEOTIDE RTIS, BY REGION, 2018-2023 (USD MILLION)
TABLE 42. GLOBAL ANTIVIRAL THERAPEUTICS MARKET SIZE, BY NUCLEOTIDE RTIS, BY REGION, 2024-2030 (USD MILLION)
TABLE 43. GLOBAL ANTIVIRAL THERAPEUTICS MARKET SIZE, BY DISTRIBUTION, 2018-2023 (USD MILLION)
TABLE 44. GLOBAL ANTIVIRAL THERAPEUTICS MARKET SIZE, BY DISTRIBUTION, 2024-2030 (USD MILLION)
TABLE 45. GLOBAL ANTIVIRAL THERAPEUTICS MARKET SIZE, BY HOSPITAL PHARMACY, BY REGION, 2018-2023 (USD MILLION)
TABLE 46. GLOBAL ANTIVIRAL THERAPEUTICS MARKET SIZE, BY HOSPITAL PHARMACY, BY REGION, 2024-2030 (USD MILLION)
TABLE 47. GLOBAL ANTIVIRAL THERAPEUTICS MARKET SIZE, BY INDEPENDENT PHARMACY & DRUG STORE, BY REGION, 2018-2023 (USD MILLION)
TABLE 48. GLOBAL ANTIVIRAL THERAPEUTICS MARKET SIZE, BY INDEPENDENT PHARMACY & DRUG STORE, BY REGION, 2024-2030 (USD MILLION)
TABLE 49. GLOBAL ANTIVIRAL THERAPEUTICS MARKET SIZE, BY ONLINE PHARMACY, BY REGION, 2018-2023 (USD MILLION)
TABLE 50. GLOBAL ANTIVIRAL THERAPEUTICS MARKET SIZE, BY ONLINE PHARMACY, BY REGION, 2024-2030 (USD MILLION)
TABLE 51. AMERICAS ANTIVIRAL THERAPEUTICS MARKET SIZE, BY DRUG, 2018-2023 (USD MILLION)
TABLE 52. AMERICAS ANTIVIRAL THERAPEUTICS MARKET SIZE, BY DRUG, 2024-2030 (USD MILLION)
TABLE 53. AMERICAS ANTIVIRAL THERAPEUTICS MARKET SIZE, BY THERAPY, 2018-2023 (USD MILLION)
TABLE 54. AMERICAS ANTIVIRAL THERAPEUTICS MARKET SIZE, BY THERAPY, 2024-2030 (USD MILLION)
TABLE 55. AMERICAS ANTIVIRAL THERAPEUTICS MARKET SIZE, BY DNA POLYMERASE INHIBITORS, 2018-2023 (USD MILLION)
TABLE 56. AMERICAS ANTIVIRAL THERAPEUTICS MARKET SIZE, BY DNA POLYMERASE INHIBITORS, 2024-2030 (USD MILLION)
TABLE 57. AMERICAS ANTIVIRAL THERAPEUTICS MARKET SIZE, BY REVERSE TRANSCRIPTASE INHIBITORS, 2018-2023 (USD MILLION)
TABLE 58. AMERICAS ANTIVIRAL THERAPEUTICS MARKET SIZE, BY REVERSE TRANSCRIPTASE INHIBITORS, 2024-2030 (USD MILLION)
TABLE 59. AMERICAS ANTIVIRAL THERAPEUTICS MARKET SIZE, BY DISTRIBUTION, 2018-2023 (USD MILLION)
TABLE 60. AMERICAS ANTIVIRAL THERAPEUTICS MARKET SIZE, BY DISTRIBUTION, 2024-2030 (USD MILLION)
TABLE 61. AMERICAS ANTIVIRAL THERAPEUTICS MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
TABLE 62. AMERICAS ANTIVIRAL THERAPEUTICS MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
TABLE 63. ARGENTINA ANTIVIRAL THERAPEUTICS MARKET SIZE, BY DRUG, 2018-2023 (USD MILLION)
TABLE 64. ARGENTINA ANTIVIRAL THERAPEUTICS MARKET SIZE, BY DRUG, 2024-2030 (USD MILLION)
TABLE 65. ARGENTINA ANTIVIRAL THERAPEUTICS MARKET SIZE, BY THERAPY, 2018-2023 (USD MILLION)
TABLE 66. ARGENTINA ANTIVIRAL THERAPEUTICS MARKET SIZE, BY THERAPY, 2024-2030 (USD MILLION)
TABLE 67. ARGENTINA ANTIVIRAL THERAPEUTICS MARKET SIZE, BY DNA POLYMERASE INHIBITORS, 2018-2023 (USD MILLION)
TABLE 68. ARGENTINA ANTIVIRAL THERAPEUTICS MARKET SIZE, BY DNA POLYMERASE INHIBITORS, 2024-2030 (USD MILLION)
TABLE 69. ARGENTINA ANTIVIRAL THERAPEUTICS MARKET SIZE, BY REVERSE TRANSCRIPTASE INHIBITORS, 2018-2023 (USD MILLION)
TABLE 70. ARGENTINA ANTIVIRAL THERAPEUTICS MARKET SIZE, BY REVERSE TRANSCRIPTASE INHIBITORS, 2024-2030 (USD MILLION)
TABLE 71. ARGENTINA ANTIVIRAL THERAPEUTICS MARKET SIZE, BY DISTRIBUTION, 2018-2023 (USD MILLION)
TABLE 72. ARGENTINA ANTIVIRAL THERAPEUTICS MARKET SIZE, BY DISTRIBUTION, 2024-2030 (USD MILLION)
TABLE 73. BRAZIL ANTIVIRAL THERAPEUTICS MARKET SIZE, BY DRUG, 2018-2023 (USD MILLION)
TABLE 74. BRAZIL ANTIVIRAL THERAPEUTICS MARKET SIZE, BY DRUG, 2024-2030 (USD MILLION)
TABLE 75. BRAZIL ANTIVIRAL THERAPEUTICS MARKET SIZE, BY THERAPY, 2018-2023 (USD MILLION)
TABLE 76. BRAZIL ANTIVIRAL THERAPEUTICS MARKET SIZE, BY THERAPY, 2024-2030 (USD MILLION)
TABLE 77. BRAZIL ANTIVIRAL THERAPEUTICS MARKET SIZE, BY DNA POLYMERASE INHIBITORS, 2018-2023 (USD MILLION)
TABLE 78. BRAZIL ANTIVIRAL THERAPEUTICS MARKET SIZE, BY DNA POLYMERASE INHIBITORS, 2024-2030 (USD MILLION)
TABLE 79. BRAZIL ANTIVIRAL THERAPEUTICS MARKET SIZE, BY REVERSE TRANSCRIPTASE INHIBITORS, 2018-2023 (USD MILLION)
TABLE 80. BRAZIL ANTIVIRAL THERAPEUTICS MARKET SIZE, BY REVERSE TRANSCRIPTASE INHIBITORS, 2024-2030 (USD MILLION)
TABLE 81. BRAZIL ANTIVIRAL THERAPEUTICS MARKET SIZE, BY DISTRIBUTION, 2018-2023 (USD MILLION)
TABLE 82. BRAZIL ANTIVIRAL THERAPEUTICS MARKET SIZE, BY DISTRIBUTION, 2024-2030 (USD MILLION)
TABLE 83. CANADA ANTIVIRAL THERAPEUTICS MARKET SIZE, BY DRUG, 2018-2023 (USD MILLION)
TABLE 84. CANADA ANTIVIRAL THERAPEUTICS MARKET SIZE, BY DRUG, 2024-2030 (USD MILLION)
TABLE 85. CANADA ANTIVIRAL THERAPEUTICS MARKET SIZE, BY THERAPY, 2018-2023 (USD MILLION)
TABLE 86. CANADA ANTIVIRAL THERAPEUTICS MARKET SIZE, BY THERAPY, 2024-2030 (USD MILLION)
TABLE 87. CANADA ANTIVIRAL THERAPEUTICS MARKET SIZE, BY DNA POLYMERASE INHIBITORS, 2018-2023 (USD MILLION)
TABLE 88. CANADA ANTIVIRAL THERAPEUTICS MARKET SIZE, BY DNA POLYMERASE INHIBITORS, 2024-2030 (USD MILLION)
TABLE 89. CANADA ANTIVIRAL THERAPEUTICS MARKET SIZE, BY REVERSE TRANSCRIPTASE INHIBITORS, 2018-2023 (USD MILLION)
TABLE 90. CANADA ANTIVIRAL THERAPEUTICS MARKET SIZE, BY REVERSE TRANSCRIPTASE INHIBITORS, 2024-2030 (USD MILLION)
TABLE 91. CANADA ANTIVIRAL THERAPEUTICS MARKET SIZE, BY DISTRIBUTION, 2018-2023 (USD MILLION)
TABLE 92. CANADA ANTIVIRAL THERAPEUTICS MARKET SIZE, BY DISTRIBUTION, 2024-2030 (USD MILLION)
TABLE 93. MEXICO ANTIVIRAL THERAPEUTICS MARKET SIZE, BY DRUG, 2018-2023 (USD MILLION)
TABLE 94. MEXICO ANTIVIRAL THERAPEUTICS MARKET SIZE, BY DRUG, 2024-2030 (USD MILLION)
TABLE 95. MEXICO ANTIVIRAL THERAPEUTICS MARKET SIZE, BY THERAPY, 2018-2023 (USD MILLION)
TABLE 96. MEXICO ANTIVIRAL THERAPEUTICS MARKET SIZE, BY THERAPY, 2024-2030 (USD MILLION)
TABLE 97. MEXICO ANTIVIRAL THERAPEUTICS MARKET SIZE, BY DNA POLYMERASE INHIBITORS, 2018-2023 (USD MILLION)
TABLE 98. MEXICO ANTIVIRAL THERAPEUTICS MARKET SIZE, BY DNA POLYMERASE INHIBITORS, 2024-2030 (USD MILLION)
TABLE 99. MEXICO ANTIVIRAL THERAPEUTICS MARKET SIZE, BY REVERSE TRANSCRIPTASE INHIBITORS, 2018-2023 (USD MILLION)
TABLE 100. MEXICO ANTIVIRAL THERAPEUTICS MARKET SIZE, BY REVERSE TRANSCRIPTASE INHIBITORS, 2024-2030 (USD MILLION)
TABLE 101. MEXICO ANTIVIRAL THERAPEUTICS MARKET SIZE, BY DISTRIBUTION, 2018-2023 (USD MILLION)
TABLE 102. MEXICO ANTIVIRAL THERAPEUTICS MARKET SIZE, BY DISTRIBUTION, 2024-2030 (USD MILLION)
TABLE 103. UNITED STATES ANTIVIRAL THERAPEUTICS MARKET SIZE, BY DRUG, 2018-2023 (USD MILLION)
TABLE 104. UNITED STATES ANTIVIRAL THERAPEUTICS MARKET SIZE, BY DRUG, 2024-2030 (USD MILLION)
TABLE 105. UNITED STATES ANTIVIRAL THERAPEUTICS MARKET SIZE, BY THERAPY, 2018-2023 (USD MILLION)
TABLE 106. UNITED STATES ANTIVIRAL THERAPEUTICS MARKET SIZE, BY THERAPY, 2024-2030 (USD MILLION)
TABLE 107. UNITED STATES ANTIVIRAL THERAPEUTICS MARKET SIZE, BY DNA POLYMERASE INHIBITORS, 2018-2023 (USD MILLION)
TABLE 108. UNITED STATES ANTIVIRAL THERAPEUTICS MARKET SIZE, BY DNA POLYMERASE INHIBITORS, 2024-2030 (USD MILLION)
TABLE 109. UNITED STATES ANTIVIRAL THERAPEUTICS MARKET SIZE, BY REVERSE TRANSCRIPTASE INHIBITORS, 2018-2023 (USD MILLION)
TABLE 110. UNITED STATES ANTIVIRAL THERAPEUTICS MARKET SIZE, BY REVERSE TRANSCRIPTASE INHIBITORS, 2024-2030 (USD MILLION)
TABLE 111. UNITED STATES ANTIVIRAL THERAPEUTICS MARKET SIZE, BY DISTRIBUTION, 2018-2023 (USD MILLION)
TABLE 112. UNITED STATES ANTIVIRAL THERAPEUTICS MARKET SIZE, BY DISTRIBUTION, 2024-2030 (USD MILLION)
TABLE 113. UNITED STATES ANTIVIRAL THERAPEUTICS MARKET SIZE, BY STATE, 2018-2023 (USD MILLION)
TABLE 114. UNITED STATES ANTIVIRAL THERAPEUTICS MARKET SIZE, BY STATE, 2024-2030 (USD MILLION)
TABLE 115. ASIA-PACIFIC ANTIVIRAL THERAPEUTICS MARKET SIZE, BY DRUG, 2018-2023 (USD MILLION)
TABLE 116. ASIA-PACIFIC ANTIVIRAL THERAPEUTICS MARKET SIZE, BY DRUG, 2024-2030 (USD MILLION)
TABLE 117. ASIA-PACIFIC ANTIVIRAL THERAPEUTICS MARKET SIZE, BY THERAPY, 2018-2023 (USD MILLION)
TABLE 118. ASIA-PACIFIC ANTIVIRAL THERAPEUTICS MARKET SIZE, BY THERAPY, 2024-2030 (USD MILLION)
TABLE 119. ASIA-PACIFIC ANTIVIRAL THERAPEUTICS MARKET SIZE, BY DNA POLYMERASE INHIBITORS, 2018-2023 (USD MILLION)
TABLE 120. ASIA-PACIFIC ANTIVIRAL THERAPEUTICS MARKET SIZE, BY DNA POLYMERASE INHIBITORS, 2024-2030 (USD MILLION)
TABLE 121. ASIA-PACIFIC ANTIVIRAL THERAPEUTICS MARKET SIZE, BY REVERSE TRANSCRIPTASE INHIBITORS, 2018-2023 (USD MILLION)
TABLE 122. ASIA-PACIFIC ANTIVIRAL THERAPEUTICS MARKET SIZE, BY REVERSE TRANSCRIPTASE INHIBITORS, 2024-2030 (USD MILLION)
TABLE 123. ASIA-PACIFIC ANTIVIRAL THERAPEUTICS MARKET SIZE, BY DISTRIBUTION, 2018-2023 (USD MILLION)
TABLE 124. ASIA-PACIFIC ANTIVIRAL THERAPEUTICS MARKET SIZE, BY DISTRIBUTION, 2024-2030 (USD MILLION)
TABLE 125. ASIA-PACIFIC ANTIVIRAL THERAPEUTICS MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
TABLE 126. ASIA-PACIFIC ANTIVIRAL THERAPEUTICS MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
TABLE 127. AUSTRALIA ANTIVIRAL THERAPEUTICS MARKET SIZE, BY DRUG, 2018-2023 (USD MILLION)
TABLE 128. AUSTRALIA ANTIVIRAL THERAPEUTICS MARKET SIZE, BY DRUG, 2024-2030 (USD MILLION)
TABLE 129. AUSTRALIA ANTIVIRAL THERAPEUTICS MARKET SIZE, BY THERAPY, 2018-2023 (USD MILLION)
TABLE 130. AUSTRALIA ANTIVIRAL THERAPEUTICS MARKET SIZE, BY THERAPY, 2024-2030 (USD MILLION)
TABLE 131. AUSTRALIA ANTIVIRAL THERAPEUTICS MARKET SIZE, BY DNA POLYMERASE INHIBITORS, 2018-2023 (USD MILLION)
TABLE 132. AUSTRALIA ANTIVIRAL THERAPEUTICS MARKET SIZE, BY DNA POLYMERASE INHIBITORS, 2024-2030 (USD MILLION)
TABLE 133. AUSTRALIA ANTIVIRAL THERAPEUTICS MARKET SIZE, BY REVERSE TRANSCRIPTASE INHIBITORS, 2018-2023 (USD MILLION)
TABLE 134. AUSTRALIA ANTIVIRAL THERAPEUTICS MARKET SIZE, BY REVERSE TRANSCRIPTASE INHIBITORS, 2024-2030 (USD MILLION)
TABLE 135. AUSTRALIA ANTIVIRAL THERAPEUTICS MARKET SIZE, BY DISTRIBUTION, 2018-2023 (USD MILLION)
TABLE 136. AUSTRALIA ANTIVIRAL THERAPEUTICS MARKET SIZE, BY DISTRIBUTION, 2024-2030 (USD MILLION)
TABLE 137. CHINA ANTIVIRAL THERAPEUTICS MARKET SIZE, BY DRUG, 2018-2023 (USD MILLION)
TABLE 138. CHINA ANTIVIRAL THERAPEUTICS MARKET SIZE, BY DRUG, 2024-2030 (USD MILLION)
TABLE 139. CHINA ANTIVIRAL THERAPEUTICS MARKET SIZE, BY THERAPY, 2018-2023 (USD MILLION)
TABLE 140. CHINA ANTIVIRAL THERAPEUTICS MARKET SIZE, BY THERAPY, 2024-2030 (USD MILLION)
TABLE 141. CHINA ANTIVIRAL THERAPEUTICS MARKET SIZE, BY DNA POLYMERASE INHIBITORS, 2018-2023 (USD MILLION)
TABLE 142. CHINA ANTIVIRAL THERAPEUTICS MARKET SIZE, BY DNA POLYMERASE INHIBITORS, 2024-2030 (USD MILLION)
TABLE 143. CHINA ANTIVIRAL THERAPEUTICS MARKET SIZE, BY REVERSE TRANSCRIPTASE INHIBITORS, 2018-2023 (USD MILLION)
TABLE 144. CHINA ANTIVIRAL THERAPEUTICS MARKET SIZE, BY REVERSE TRANSCRIPTASE INHIBITORS, 2024-2030 (USD MILLION)
TABLE 145. CHINA ANTIVIRAL THERAPEUTICS MARKET SIZE, BY DISTRIBUTION, 2018-2023 (USD MILLION)
TABLE 146. CHINA ANTIVIRAL THERAPEUTICS MARKET SIZE, BY DISTRIBUTION, 2024-2030 (USD MILLION)
TABLE 147. INDIA ANTIVIRAL THERAPEUTICS MARKET SIZE, BY DRUG, 2018-2023 (USD MILLION)
TABLE 148. INDIA ANTIVIRAL THERAPEUTICS MARKET SIZE, BY DRUG, 2024-2030 (USD MILLION)
TABLE 149. INDIA ANTIVIRAL THERAPEUTICS MARKET SIZE, BY THERAPY, 2018-2023 (USD MILLION)
TABLE 150. INDIA ANTIVIRAL THERAPEUTICS MARKET SIZE, BY THERAPY, 2024-2030 (USD MILLION)
TABLE 151. INDIA ANTIVIRAL THERAPEUTICS MARKET SIZE, BY DNA POLYMERASE INHIBITORS, 2018-2023 (USD MILLION)
TABLE 152. INDIA ANTIVIRAL THERAPEUTICS MARKET SIZE, BY DNA POLYMERASE INHIBITORS, 2024-2030 (USD MILLION)
TABLE 153. INDIA ANTIVIRAL THERAPEUTICS MARKET SIZE, BY REVERSE TRANSCRIPTASE INHIBITORS, 2018-2023 (USD MILLION)
TABLE 154. INDIA ANTIVIRAL THERAPEUTICS MARKET SIZE, BY REVERSE TRANSCRIPTASE INHIBITORS, 2024-2030 (USD MILLION)
TABLE 155. INDIA ANTIVIRAL THERAPEUTICS MARKET SIZE, BY DISTRIBUTION, 2018-2023 (USD MILLION)
TABLE 156. INDIA ANTIVIRAL THERAPEUTICS MARKET SIZE, BY DISTRIBUTION, 2024-2030 (USD MILLION)
TABLE 157. INDONESIA ANTIVIRAL THERAPEUTICS MARKET SIZE, BY DRUG, 2018-2023 (USD MILLION)
TABLE 158. INDONESIA ANTIVIRAL THERAPEUTICS MARKET SIZE, BY DRUG, 2024-2030 (USD MILLION)
TABLE 159. INDONESIA ANTIVIRAL THERAPEUTICS MARKET SIZE, BY THERAPY, 2018-2023 (USD MILLION)
TABLE 160. INDONESIA ANTIVIRAL THERAPEUTICS MARKET SIZE, BY THERAPY, 2024-2030 (USD MILLION)
TABLE 161. INDONESIA ANTIVIRAL THERAPEUTICS MARKET SIZE, BY DNA POLYMERASE INHIBITORS, 2018-2023 (USD MILLION)
TABLE 162. INDONESIA ANTIVIRAL THERAPEUTICS MARKET SIZE, BY DNA POLYMERASE INHIBITORS, 2024-2030 (USD MILLION)
TABLE 163. INDONESIA ANTIVIRAL THERAPEUTICS MARKET SIZE, BY REVERSE TRANSCRIPTASE INHIBITORS, 2018-2023 (USD MILLION)
TABLE 164. INDONESIA ANTIVIRAL THERAPEUTICS MARKET SIZE, BY REVERSE TRANSCRIPTASE INHIBITORS, 2024-2030 (USD MILLION)
TABLE 165. INDONESIA ANTIVIRAL THERAPEUTICS MARKET SIZE, BY DISTRIBUTION, 2018-2023 (USD MILLION)
TABLE 166. INDONESIA ANTIVIRAL THERAPEUTICS MARKET SIZE, BY DISTRIBUTION, 2024-2030 (USD MILLION)
TABLE 167. JAPAN ANTIVIRAL THERAPEUTICS MARKET SIZE, BY DRUG, 2018-2023 (USD MILLION)
TABLE 168. JAPAN ANTIVIRAL THERAPEUTICS MARKET SIZE, BY DRUG, 2024-2030 (USD MILLION)
TABLE 169. JAPAN ANTIVIRAL THERAPEUTICS MARKET SIZE, BY THERAPY, 2018-2023 (USD MILLION)
TABLE 170. JAPAN ANTIVIRAL THERAPEUTICS MARKET SIZE, BY THERAPY, 2024-2030 (USD MILLION)
TABLE 171. JAPAN ANTIVIRAL THERAPEUTICS MARKET SIZE, BY DNA POLYMERASE INHIBITORS, 2018-2023 (USD MILLION)
TABLE 172. JAPAN ANTIVIRAL THERAPEUTICS MARKET SIZE, BY DNA POLYMERASE INHIBITORS, 2024-2030 (USD MILLION)
TABLE 173. JAPAN ANTIVIRAL THERAPEUTICS MARKET SIZE, BY REVERSE TRANSCRIPTASE INHIBITORS, 2018-2023 (USD MILLION)
TABLE 174. JAPAN ANTIVIRAL THERAPEUTICS MARKET SIZE, BY REVERSE TRANSCRIPTASE INHIBITORS, 2024-2030 (USD MILLION)
TABLE 175. JAPAN ANTIVIRAL THERAPEUTICS MARKET SIZE, BY DISTRIBUTION, 2018-2023 (USD MILLION)
TABLE 176. JAPAN ANTIVIRAL THERAPEUTICS MARKET SIZE, BY DISTRIBUTION, 2024-2030 (USD MILLION)
TABLE 177. MALAYSIA ANTIVIRAL THERAPEUTICS MARKET SIZE, BY DRUG, 2018-2023 (USD MILLION)
TABLE 178. MALAYSIA ANTIVIRAL THERAPEUTICS MARKET SIZE, BY DRUG, 2024-2030 (USD MILLION)
TABLE 179. MALAYSIA ANTIVIRAL THERAPEUTICS MARKET SIZE, BY THERAPY, 2018-2023 (USD MILLION)
TABLE 180. MALAYSIA ANTIVIRAL THERAPEUTICS MARKET SIZE, BY THERAPY, 2024-2030 (USD MILLION)
TABLE 181. MALAYSIA ANTIVIRAL THERAPEUTICS MARKET SIZE, BY DNA POLYMERASE INHIBITORS, 2018-2023 (USD MILLION)
TABLE 182. MALAYSIA ANTIVIRAL THERAPEUTICS MARKET SIZE, BY DNA POLYMERASE INHIBITORS, 2024-2030 (USD MILLION)
TABLE 183. MALAYSIA ANTIVIRAL THERAPEUTICS MARKET SIZE, BY REVERSE TRANSCRIPTASE INHIBITORS, 2018-2023 (USD MILLION)
TABLE 184. MALAYSIA ANTIVIRAL THERAPEUTICS MARKET SIZE, BY REVERSE TRANSCRIPTASE INHIBITORS, 2024-2030 (USD MILLION)
TABLE 185. MALAYSIA ANTIVIRAL THERAPEUTICS MARKET SIZE, BY DISTRIBUTION, 2018-2023 (USD MILLION)
TABLE 186. MALAYSIA ANTIVIRAL THERAPEUTICS MARKET SIZE, BY DISTRIBUTION, 2024-2030 (USD MILLION)
TABLE 187. PHILIPPINES ANTIVIRAL THERAPEUTICS MARKET SIZE, BY DRUG, 2018-2023 (USD MILLION)
TABLE 188. PHILIPPINES ANTIVIRAL THERAPEUTICS MARKET SIZE, BY DRUG, 2024-2030 (USD MILLION)
TABLE 189. PHILIPPINES ANTIVIRAL THERAPEUTICS MARKET SIZE, BY THERAPY, 2018-2023 (USD MILLION)
TABLE 190. PHILIPPINES ANTIVIRAL THERAPEUTICS MARKET SIZE, BY THERAPY, 2024-2030 (USD MILLION)
TABLE 191. PHILIPPINES ANTIVIRAL THERAPEUTICS MARKET SIZE, BY DNA POLYMERASE INHIBITORS, 2018-2023 (USD MILLION)
TABLE 192. PHILIPPINES ANTIVIRAL THERAPEUTICS MARKET SIZE, BY DNA POLYMERASE INHIBITORS, 2024-2030 (USD MILLION)
TABLE 193. PHILIPPINES ANTIVIRAL THERAPEUTICS MARKET SIZE, BY REVERSE TRANSCRIPTASE INHIBITORS, 2018-2023 (USD MILLION)
TABLE 194. PHILIPPINES ANTIVIRAL THERAPEUTICS MARKET SIZE, BY REVERSE TRANSCRIPTASE INHIBITORS, 2024-2030 (USD MILLION)
TABLE 195. PHILIPPINES ANTIVIRAL THERAPEUTICS MARKET SIZE, BY DISTRIBUTION, 2018-2023 (USD MILLION)
TABLE 196. PHILIPPINES ANTIVIRAL THERAPEUTICS MARKET SIZE, BY DISTRIBUTION, 2024-2030 (USD MILLION)
TABLE 197. SINGAPORE ANTIVIRAL THERAPEUTICS MARKET SIZE, BY DRUG, 2018-2023 (USD MILLION)
TABLE 198. SINGAPORE ANTIVIRAL THERAPEUTICS MARKET SIZE, BY DRUG, 2024-2030 (USD MILLION)
TABLE 199. SINGAPORE ANTIVIRAL THERAPEUTICS MARKET SIZE, BY THERAPY, 2018-2023 (USD MILLION)
TABLE 200. SINGAPORE ANTIVIRAL THERAPEUTICS MARKET SIZE, BY THERAPY, 2024-2030 (USD MILLION)
TABLE 201. SINGAPORE ANTIVIRAL THERAPEUTICS MARKET SIZE, BY DNA POLYMERASE INHIBITORS, 2018-2023 (USD MILLION)
TABLE 202. SINGAPORE ANTIVIRAL THERAPEUTICS MARKET SIZE, BY DNA POLYMERASE INHIBITORS, 2024-2030 (USD MILLION)
TABLE 203. SINGAPORE ANTIVIRAL THERAPEUTICS MARKET SIZE, BY REVERSE TRANSCRIPTASE INHIBITORS, 2018-2023 (USD MILLION)
TABLE 204. SINGAPORE ANTIVIRAL THERAPEUTICS MARKET SIZE, BY REVERSE TRANSCRIPTASE INHIBITORS, 2024-2030 (USD MILLION)
TABLE 205. SINGAPORE ANTIVIRAL THERAPEUTICS MARKET SIZE, BY DISTRIBUTION, 2018-2023 (USD MILLION)
TABLE 206. SINGAPORE ANTIVIRAL THERAPEUTICS MARKET SIZE, BY DISTRIBUTION, 2024-2030 (USD MILLION)
TABLE 207. SOUTH KOREA ANTIVIRAL THERAPEUTICS MARKET SIZE, BY DRUG, 2018-2023 (USD MILLION)
TABLE 208. SOUTH KOREA ANTIVIRAL THERAPEUTICS MARKET SIZE, BY DRUG, 2024-2030 (USD MILLION)
TABLE 209. SOUTH KOREA ANTIVIRAL THERAPEUTICS MARKET SIZE, BY THERAPY, 2018-2023 (USD MILLION)
TABLE 210. SOUTH KOREA ANTIVIRAL THERAPEUTICS MARKET SIZE, BY THERAPY, 2024-2030 (USD MILLION)
TABLE 211. SOUTH KOREA ANTIVIRAL THERAPEUTICS MARKET SIZE, BY DNA POLYMERASE INHIBITORS, 2018-2023 (USD MILLION)
TABLE 212. SOUTH KOREA ANTIVIRAL THERAPEUTICS MARKET SIZE, BY DNA POLYMERASE INHIBITORS, 2024-2030 (USD MILLION)
TABLE 213. SOUTH KOREA ANTIVIRAL THERAPEUTICS MARKET SIZE, BY REVERSE TRANSCRIPTASE INHIBITORS, 2018-2023 (USD MILLION)
TABLE 214. SOUTH KOREA ANTIVIRAL THERAPEUTICS MARKET SIZE, BY REVERSE TRANSCRIPTASE INHIBITORS, 2024-2030 (USD MILLION)
TABLE 215. SOUTH KOREA ANTIVIRAL THERAPEUTICS MARKET SIZE, BY DISTRIBUTION, 2018-2023 (USD MILLION)
TABLE 216. SOUTH KOREA ANTIVIRAL THERAPEUTICS MARKET SIZE, BY DISTRIBUTION, 2024-2030 (USD MILLION)
TABLE 217. TAIWAN ANTIVIRAL THERAPEUTICS MARKET SIZE, BY DRUG, 2018-2023 (USD MILLION)
TABLE 218. TAIWAN ANTIVIRAL THERAPEUTICS MARKET SIZE, BY DRUG, 2024-2030 (USD MILLION)
TABLE 219. TAIWAN ANTIVIRAL THERAPEUTICS MARKET SIZE, BY THERAPY, 2018-2023 (USD MILLION)
TABLE 220. TAIWAN ANTIVIRAL THERAPEUTICS MARKET SIZE, BY THERAPY, 2024-2030 (USD MILLION)
TABLE 221. TAIWAN ANTIVIRAL THERAPEUTICS MARKET SIZE, BY DNA POLYMERASE INHIBITORS, 2018-2023 (USD MILLION)
TABLE 222. TAIWAN ANTIVIRAL THERAPEUTICS MARKET SIZE, BY DNA POLYMERASE INHIBITORS, 2024-2030 (USD MILLION)
TABLE 223. TAIWAN ANTIVIRAL THERAPEUTICS MARKET SIZE, BY REVERSE TRANSCRIPTASE INHIBITORS, 2018-2023 (USD MILLION)
TABLE 224. TAIWAN ANTIVIRAL THERAPEUTICS MARKET SIZE, BY REVERSE TRANSCRIPTASE INHIBITORS, 2024-2030 (USD MILLION)
TABLE 225. TAIWAN ANTIVIRAL THERAPEUTICS MARKET SIZE, BY DISTRIBUTION, 2018-2023 (USD MILLION)
TABLE 226. TAIWAN ANTIVIRAL THERAPEUTICS MARKET SIZE, BY DISTRIBUTION, 2024-2030 (USD MILLION)
TABLE 227. THAILAND ANTIVIRAL THERAPEUTICS MARKET SIZE, BY DRUG, 2018-2023 (USD MILLION)
TABLE 228. THAILAND ANTIVIRAL THERAPEUTICS MARKET SIZE, BY DRUG, 2024-2030 (USD MILLION)
TABLE 229. THAILAND ANTIVIRAL THERAPEUTICS MARKET SIZE, BY THERAPY, 2018-2023 (USD MILLION)
TABLE 230. THAILAND ANTIVIRAL THERAPEUTICS MARKET SIZE, BY THERAPY, 2024-2030 (USD MILLION)
TABLE 231. THAILAND ANTIVIRAL THERAPEUTICS MARKET SIZE, BY DNA POLYMERASE INHIBITORS, 2018-2023 (USD MILLION)
TABLE 232. THAILAND ANTIVIRAL THERAPEUTICS MARKET SIZE, BY DNA POLYMERASE INHIBITORS, 2024-2030 (USD MILLION)
TABLE 233. THAILAND ANTIVIRAL THERAPEUTICS MARKET SIZE, BY REVERSE TRANSCRIPTASE INHIBITORS, 2018-2023 (USD MILLION)
TABLE 234. THAILAND ANTIVIRAL THERAPEUTICS MARKET SIZE, BY REVERSE TRANSCRIPTASE INHIBITORS, 2024-2030 (USD MILLION)
TABLE 235. THAILAND ANTIVIRAL THERAPEUTICS MARKET SIZE, BY DISTRIBUTION, 2018-2023 (USD MILLION)
TABLE 236. THAILAND ANTIVIRAL THERAPEUTICS MARKET SIZE, BY DISTRIBUTION, 2024-2030 (USD MILLION)
TABLE 237. VIETNAM ANTIVIRAL THERAPEUTICS MARKET SIZE, BY DRUG, 2018-2023 (USD MILLION)
TABLE 238. VIETNAM ANTIVIRAL THERAPEUTICS MARKET SIZE, BY DRUG, 2024-2030 (USD MILLION)
TABLE 239. VIETNAM ANTIVIRAL THERAPEUTICS MARKET SIZE, BY THERAPY, 2018-2023 (USD MILLION)
TABLE 240. VIETNAM ANTIVIRAL THERAPEUTICS MARKET SIZE, BY THERAPY, 2024-2030 (USD MILLION)
TABLE 241. VIETNAM ANTIVIRAL THERAPEUTICS MARKET SIZE, BY DNA POLYMERASE INHIBITORS, 2018-2023 (USD MILLION)
TABLE 242. VIETNAM ANTIVIRAL THERAPEUTICS MARKET SIZE, BY DNA POLYMERASE INHIBITORS, 2024-2030 (USD MILLION)
TABLE 243. VIETNAM ANTIVIRAL THERAPEUTICS MARKET SIZE, BY REVERSE TRANSCRIPTASE INHIBITORS, 2018-2023 (USD MILLION)
TABLE 244. VIETNAM ANTIVIRAL THERAPEUTICS MARKET SIZE, BY REVERSE TRANSCRIPTASE INHIBITORS, 2024-2030 (USD MILLION)
TABLE 245. VIETNAM ANTIVIRAL THERAPEUTICS MARKET SIZE, BY DISTRIBUTION, 2018-2023 (USD MILLION)
TABLE 246. VIETNAM ANTIVIRAL THERAPEUTICS MARKET SIZE, BY DISTRIBUTION, 2024-2030 (USD MILLION)
TABLE 247. EUROPE, MIDDLE EAST & AFRICA ANTIVIRAL THERAPEUTICS MARKET SIZE, BY DRUG, 2018-2023 (USD MILLION)
TABLE 248. EUROPE, MIDDLE EAST & AFRICA ANTIVIRAL THERAPEUTICS MARKET SIZE, BY DRUG, 2024-2030 (USD MILLION)
TABLE 249. EUROPE, MIDDLE EAST & AFRICA ANTIVIRAL THERAPEUTICS MARKET SIZE, BY THERAPY, 2018-2023 (USD MILLION)
TABLE 250. EUROPE, MIDDLE EAST & AFRICA ANTIVIRAL THERAPEUTICS MARKET SIZE, BY THERAPY, 2024-2030 (USD MILLION)
TABLE 251. EUROPE, MIDDLE EAST & AFRICA ANTIVIRAL THERAPEUTICS MARKET SIZE, BY DNA POLYMERASE INHIBITORS, 2018-2023 (USD MILLION)
TABLE 252. EUROPE, MIDDLE EAST & AFRICA ANTIVIRAL THERAPEUTICS MARKET SIZE, BY DNA POLYMERASE INHIBITORS, 2024-2030 (USD MILLION)
TABLE 253. EUROPE, MIDDLE EAST & AFRICA ANTIVIRAL THERAPEUTICS MARKET SIZE, BY REVERSE TRANSCRIPTASE INHIBITORS, 2018-2023 (USD MILLION)
TABLE 254. EUROPE, MIDDLE EAST & AFRICA ANTIVIRAL THERAPEUTICS MARKET SIZE, BY REVERSE TRANSCRIPTASE INHIBITORS, 2024-2030 (USD MILLION)
TABLE 255. EUROPE, MIDDLE EAST & AFRICA ANTIVIRAL THERAPEUTICS MARKET SIZE, BY DISTRIBUTION, 2018-2023 (USD MILLION)
TABLE 256. EUROPE, MIDDLE EAST & AFRICA ANTIVIRAL THERAPEUTICS MARKET SIZE, BY DISTRIBUTION, 2024-2030 (USD MILLION)
TABLE 257. EUROPE, MIDDLE EAST & AFRICA ANTIVIRAL THERAPEUTICS MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
TABLE 258. EUROPE, MIDDLE EAST & AFRICA ANTIVIRAL THERAPEUTICS MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
TABLE 259. DENMARK ANTIVIRAL THERAPEUTICS MARKET SIZE, BY DRUG, 2018-2023 (USD MILLION)
TABLE 260. DENMARK ANTIVIRAL THERAPEUTICS MARKET SIZE, BY DRUG, 2024-2030 (USD MILLION)
TABLE 261. DENMARK ANTIVIRAL THERAPEUTICS MARKET SIZE, BY THERAPY, 2018-2023 (USD MILLION)
TABLE 262. DENMARK ANTIVIRAL THERAPEUTICS MARKET SIZE, BY THERAPY, 2024-2030 (USD MILLION)
TABLE 263. DENMARK ANTIVIRAL THERAPEUTICS MARKET SIZE, BY DNA POLYMERASE INHIBITORS, 2018-2023 (USD MILLION)
TABLE 264. DENMARK ANTIVIRAL THERAPEUTICS MARKET SIZE, BY DNA POLYMERASE INHIBITORS, 2024-2030 (USD MILLION)
TABLE 265. DENMARK ANTIVIRAL THERAPEUTICS MARKET SIZE, BY REVERSE TRANSCRIPTASE INHIBITORS, 2018-2023 (USD MILLION)
TABLE 266. DENMARK ANTIVIRAL THERAPEUTICS MARKET SIZE, BY REVERSE TRANSCRIPTASE INHIBITORS, 2024-2030 (USD MILLION)
TABLE 267. DENMARK ANTIVIRAL THERAPEUTICS MARKET SIZE, BY DISTRIBUTION, 2018-2023 (USD MILLION)
TABLE 268. DENMARK ANTIVIRAL THERAPEUTICS MARKET SIZE, BY DISTRIBUTION, 2024-2030 (USD MILLION)
TABLE 269. EGYPT ANTIVIRAL THERAPEUTICS MARKET SIZE, BY DRUG, 2018-2023 (USD MILLION)
TABLE 270. EGYPT ANTIVIRAL THERAPEUTICS MARKET SIZE, BY DRUG, 2024-2030 (USD MILLION)
TABLE 271. EGYPT ANTIVIRAL THERAPEUTICS MARKET SIZE, BY THERAPY, 2018-2023 (USD MILLION)
TABLE 272. EGYPT ANTIVIRAL THERAPEUTICS MARKET SIZE, BY THERAPY, 2024-2030 (USD MILLION)
TABLE 273. EGYPT ANTIVIRAL THERAPEUTICS MARKET SIZE, BY DNA POLYMERASE INHIBITORS, 2018-2023 (USD MILLION)
TABLE 274. EGYPT ANTIVIRAL THERAPEUTICS MARKET SIZE, BY DNA POLYMERASE INHIBITORS, 2024-2030 (USD MILLION)
TABLE 275. EGYPT ANTIVIRAL THERAPEUTICS MARKET SIZE, BY REVERSE TRANSCRIPTASE INHIBITORS, 2018-2023 (USD MILLION)
TABLE 276. EGYPT ANTIVIRAL THERAPEUTICS MARKET SIZE, BY REVERSE TRANSCRIPTASE INHIBITORS, 2024-2030 (USD MILLION)
TABLE 277. EGYPT ANTIVIRAL THERAPEUTICS MARKET SIZE, BY DISTRIBUTION, 2018-2023 (USD MILLION)
TABLE 278. EGYPT ANTIVIRAL THERAPEUTICS MARKET SIZE, BY DISTRIBUTION, 2024-2030 (USD MILLION)
TABLE 279. FINLAND ANTIVIRAL THERAPEUTICS MARKET SIZE, BY DRUG, 2018-2023 (USD MILLION)
TABLE 280. FINLAND ANTIVIRAL THERAPEUTICS MARKET SIZE, BY DRUG, 2024-2030 (USD MILLION)
TABLE 281. FINLAND ANTIVIRAL THERAPEUTICS MARKET SIZE, BY THERAPY, 2018-2023 (USD MILLION)
TABLE 282. FINLAND ANTIVIRAL THERAPEUTICS MARKET SIZE, BY THERAPY, 2024-2030 (USD MILLION)
TABLE 283. FINLAND ANTIVIRAL THERAPEUTICS MARKET SIZE, BY DNA POLYMERASE INHIBITORS, 2018-2023 (USD MILLION)
TABLE 284. FINLAND ANTIVIRAL THERAPEUTICS MARKET SIZE, BY DNA POLYMERASE INHIBITORS, 2024-2030 (USD MILLION)
TABLE 285. FINLAND ANTIVIRAL THERAPEUTICS MARKET SIZE, BY REVERSE TRANSCRIPTASE INHIBITORS, 2018-2023 (USD MILLION)
TABLE 286. FINLAND ANTIVIRAL THERAPEUTICS MARKET SIZE, BY REVERSE TRANSCRIPTASE INHIBITORS, 2024-2030 (USD MILLION)
TABLE 287. FINLAND ANTIVIRAL THERAPEUTICS MARKET SIZE, BY DISTRIBUTION, 2018-2023 (USD MILLION)
TABLE 288. FINLAND ANTIVIRAL THERAPEUTICS MARKET SIZE, BY DISTRIBUTION, 2024-2030 (USD MILLION)
TABLE 289. FRANCE ANTIVIRAL THERAPEUTICS MARKET SIZE, BY DRUG, 2018-2023 (USD MILLION)
TABLE 290. FRANCE ANTIVIRAL THERAPEUTICS MARKET SIZE, BY DRUG, 2024-2030 (USD MILLION)
TABLE 291. FRANCE ANTIVIRAL THERAPEUTICS MARKET SIZE, BY THERAPY, 2018-2023 (USD MILLION)
TABLE 292. FRANCE ANTIVIRAL THERAPEUTICS MARKET SIZE, BY THERAPY, 2024-2030 (USD MILLION)
TABLE 293. FRANCE ANTIVIRAL THERAPEUTICS MARKET SIZE, BY DNA POLYMERASE INHIBITORS, 2018-2023 (USD MILLION)
TABLE 294. FRANCE ANTIVIRAL THERAPEUTICS MARKET SIZE, BY DNA POLYMERASE INHIBITORS, 2024-2030 (USD MILLION)
TABLE 295. FRANCE ANTIVIRAL THERAPEUTICS MARKET SIZE, BY REVERSE TRANSCRIPTASE INHIBITORS, 2018-2023 (USD MILLION)
TABLE 296. FRANCE ANTIVIRAL THERAPEUTICS MARKET SIZE, BY REVERSE TRANSCRIPTASE INHIBITORS, 2024-2030 (USD MILLION)
TABLE 297. FRANCE ANTIVIRAL THERAPEUTICS MARKET SIZE, BY DISTRIBUTION, 2018-2023 (USD MILLION)
TABLE 298. FRANCE ANTIVIRAL THERAPEUTICS MARKET SIZE, BY DISTRIBUTION, 2024-2030 (USD MILLION)
TABLE 299. GERMANY ANTIVIRAL THERAPEUTICS MARKET SIZE, BY DRUG, 2018-2023 (USD MILLION)
TABLE 300. GERMANY ANTIVIRAL THERAPEUTICS MARKET SIZE, BY DRUG, 2024-2030 (USD MILLION)
TABLE 301. GERMANY ANTIVIRAL THERAPEUTICS MARKET SIZE, BY THERAPY, 2018-2023 (USD MILLION)
TABLE 302. GERMANY ANTIVIRAL THERAPEUTICS MARKET SIZE, BY THERAPY, 2024-2030 (USD MILLION)
TABLE 303. GERMANY ANTIVIRAL THERAPEUTICS MARKET SIZE, BY DNA POLYMERASE INHIBITORS, 2018-2023 (USD MILLION)
TABLE 304. GERMANY ANTIVIRAL THERAPEUTICS MARKET SIZE, BY DNA POLYMERASE INHIBITORS, 2024-2030 (USD MILLION)
TABLE 305. GERMANY ANTIVIRAL THERAPEUTICS MARKET SIZE, BY REVERSE TRANSCRIPTASE INHIBITORS, 2018-2023 (USD MILLION)
TABLE 306. GERMANY ANTIVIRAL THERAPEUTICS MARKET SIZE, BY REVERSE TRANSCRIPTASE INHIBITORS, 2024-2030 (USD MILLION)
TABLE 307. GERMANY ANTIVIRAL THERAPEUTICS MARKET SIZE, BY DISTRIBUTION, 2018-2023 (USD MILLION)
TABLE 308. GERMANY ANTIVIRAL THERAPEUTICS MARKET SIZE, BY DISTRIBUTION, 2024-2030 (USD MILLION)
TABLE 309. ISRAEL ANTIVIRAL THERAPEUTICS MARKET SIZE, BY DRUG, 2018-2023 (USD MILLION)
TABLE 310. ISRAEL ANTIVIRAL THERAPEUTICS MARKET SIZE, BY DRUG, 2024-2030 (USD MILLION)
TABLE 311. ISRAEL ANTIVIRAL THERAPEUTICS MARKET SIZE, BY THERAPY, 2018-2023 (USD MILLION)
TABLE 312. ISRAEL ANTIVIRAL THERAPEUTICS MARKET SIZE, BY THERAPY, 2024-2030 (USD MILLION)
TABLE 313. ISRAEL ANTIVIRAL THERAPEUTICS MARKET SIZE, BY DNA POLYMERASE INHIBITORS, 2018-2023 (USD MILLION)
TABLE 314. ISRAEL ANTIVIRAL THERAPEUTICS MARKET SIZE, BY DNA POLYMERASE INHIBITORS, 2024-2030 (USD MILLION)
TABLE 315. ISRAEL ANTIVIRAL THERAPEUTICS MARKET SIZE, BY REVERSE TRANSCRIPTASE INHIBITORS, 2018-2023 (USD MILLION)
TABLE 316. ISRAEL ANTIVIRAL THERAPEUTICS MARKET SIZE, BY REVERSE TRANSCRIPTASE INHIBITORS, 2024-2030 (USD MILLION)
TABLE 317. ISRAEL ANTIVIRAL THERAPEUTICS MARKET SIZE, BY DISTRIBUTION, 2018-2023 (USD MILLION)
TABLE 318. ISRAEL ANTIVIRAL THERAPEUTICS MARKET SIZE, BY DISTRIBUTION, 2024-2030 (USD MILLION)
TABLE 319. ITALY ANTIVIRAL THERAPEUTICS MARKET SIZE, BY DRUG, 2018-2023 (USD MILLION)
TABLE 320. ITALY ANTIVIRAL THERAPEUTICS MARKET SIZE, BY DRUG, 2024-2030 (USD MILLION)
TABLE 321. ITALY ANTIVIRAL THERAPEUTICS MARKET SIZE, BY THERAPY, 2018-2023 (USD MILLION)
TABLE 322. ITALY ANTIVIRAL THERAPEUTICS MARKET SIZE, BY THERAPY,